Tilray | TRLY - Lucro Bruto Sobre Vendas

Preço das Ações
9.16
Mudança Diária
-0.11 -1.19%
Mensal
-13.91%
Anual
895.65%
Q1 Previsão
9.24




Lucro Bruto Sobre Vendas Alterar Data
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Aurora Cannabis CAD 46.62M 14.33M 2025-12
Avita Medical AUD 14.31M 639K 2025-12
Canopy Growth CAD 21.9M 3.86M 2025-09
Cronos Group USD 16.19M 34.52M 2025-12
Dianthus Therapeutics USD 284K 112K 2025-12
Divis Laboratories Ltd INR 16.59B 2.05B 2025-12
Ionis Pharmaceuticals USD 195M 40M 2025-12
IQVIA Holdings USD 1.12B 32M 2025-12
Knight Therapeutics CAD 55.81M 10.98M 2025-09
Moderna USD 226M 583M 2025-12
Organigram Holdings CAD 31.84M 23.88M 2025-09
Organon & Co USD 854M 3M 2025-12
Revvity USD 421.66M 47.06M 2025-12
Tectonic Therapeutic USD 0 0 2025-03
Tilray USD 67.63M 15.62M 2025-03
Viatris USD 1.15B 223.6M 2025-12
Xeris Pharmaceuticals USD 72.15M 8.77M 2025-12